ArriVent BioPharma Inc.

AVBP | NASDAQ

Price Alert Chart Builder DCF Calculator

$29.74

+$0.84 (+2.91%)

At close: Sep 21, 2026, 4:00 PM ET

$29.74

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.35B

Enterprise Value $1.01B

Beta 1.36

Average Volume 509.67K

Shares Outstanding (Diluted) 47.61M

Shares Change YoY 36%

Institutional Ownership 93.64%

Exchange NASDAQ

ISIN US04272N1028

Price Performance

Price Change 1M 2.7%

Price Change 3M -11.9%

Price Change 6M 30.7%

Price Change YTD 43.0%

Price Change 1Y 59.7%

Price Change 3Y 48.7%

Price Change 5Y 48.7%

1M CAGR (ann.) -6.8%

1Y CAGR (ann.) 65.0%

5Y CAGR (ann.) N/A

All-Time CAGR 14.9%

Valuation

PE Ratio -8.08

Forward PE N/A

PEG Ratio -2.18

Forward PEG 0.74

PS Ratio N/A

Forward PS 45.70

PB Ratio 3.78

P/FCF Ratio -9.36

P/Adj. FCF Ratio -8.29

P/OCF Ratio -9.56

EV/Sales N/A

EV/EBIT -6.18

EV/EBITDA -6.18

EV/FCF -6.84

Earnings Yield -12.4%

FCF Yield -10.7%

Adj. FCF Yield -12.1%

Financial Health

Net Cash $372.77M

Total Debt $351K

Cash & Short-Term Investments $373.12M

Total Assets $394.72M

Current Ratio 14.16

Quick Ratio 14.16

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt -421.45

Interest Coverage 0.00

Altman Z-Score 26.95

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -12.9%

Returns

Return on Assets -41.5%

Return on Equity -50.3%

Return on Invested Capital -47.9%

Return on Capital Employed -48.0%

Return on Tangible Assets -41.5%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -21.9%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -35.0%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 8

EPS Growth Next 3Y 37.0%

Revenue Growth Next 3Y N/A

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $46

Price Target Upside 54.7%

Cash Flow

Operating Cash Flow $-147.93M

Free Cash Flow $-147.93M

Adj. Free Cash Flow $-167.02M

FCF Per Share -$3.11

OCF Per Share -$3.11

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-175.94M

EBITDA $-163.74M

Net Income $-163.74M

EPS (Diluted) -$3.68

Revenue / Employee N/A

Profit / Employee $-2.13M

Employees 77